Form 8-K - Current report:
SEC Accession No. 0001193125-23-156613
Filing Date
2023-05-30
Accepted
2023-05-30 16:24:05
Documents
21
Period of Report
2023-05-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d496018d8k.htm   iXBRL 8-K 43642
2 EX-4.1 d496018dex41.htm EX-4.1 79339
3 EX-4.2 d496018dex42.htm EX-4.2 83959
4 EX-4.3 d496018dex43.htm EX-4.3 83349
5 EX-5.1 d496018dex51.htm EX-5.1 17474
6 EX-10.1 d496018dex101.htm EX-10.1 199714
7 EX-99.1 d496018dex991.htm EX-99.1 11879
12 GRAPHIC g496018dsp107.jpg GRAPHIC 3431
13 GRAPHIC g496018dsp108.jpg GRAPHIC 2322
  Complete submission text file 0001193125-23-156613.txt   835331

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA eftr-20230526.xsd EX-101.SCH 4335
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eftr-20230526_def.xml EX-101.DEF 14095
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eftr-20230526_lab.xml EX-101.LAB 23584
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eftr-20230526_pre.xml EX-101.PRE 15128
15 EXTRACTED XBRL INSTANCE DOCUMENT d496018d8k_htm.xml XML 5585
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39866 | Film No.: 23976796
SIC: 2834 Pharmaceutical Preparations